Daniels Eric Joseph 4

What Happened

• Eric Daniels, Chief Development Officer of Kiora Pharmaceuticals (KPRX), had 929 shares withheld to satisfy his employee tax obligation upon the vesting of restricted stock. The filing records the shares at $1.95 per share, a total of about $1,812. This was a net-share settlement to cover taxes, not an open-market sale or purchase.

Key Details

• Transaction date: 2026-04-01; Filing date: 2026-04-02 (filed promptly the next day).
• Transaction type/code: F — payment of exercise price or tax liability via net share settlement (shares disposed/withheld).
• Shares involved: 929 withheld at $1.95 each; total value ~ $1,812.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Notable footnote: Form states this was a net share settlement to satisfy employee tax withholding upon vesting of restricted stock.

Context

• This transaction is a routine tax-withholding event tied to equity vesting, not an indicator of a deliberate buy or sell decision in the open market. For retail investors, such withholdings are common and do not necessarily signal management sentiment about the company's stock.